Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics
Titel:
Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics
Auteur:
Quinn, Tom M. Gaughan, Erin E. Bruce, Annya Antonelli, Jean O'Connor, Richard Li, Feng McNamara, Sarah Koch, Oliver MacKintosh, Claire Dockrell, David Walsh, Timothy Blyth, Kevin G. Church, Colin Schwarze, Jürgen Boz, Cecilia Valanciute, Asta Burgess, Matthew Emanuel, Philip Mills, Bethany Rinaldi, Giulia Hardisty, Gareth Mills, Ross Findlay, Emily Gwyer Jabbal, Sunny Duncan, Andrew Plant, Sinéad Marshall, Adam D.L. Young, Irene Russell, Kay Scholefield, Emma Nimmo, Alastair F. Nazarov, Islom B. Churchill, Grant C. McCullagh, James S.O. Ebrahimi, Kourosh H. Ferrett, Colin Templeton, Kate Rannard, Steve Owen, Andrew Moore, Anne Finlayson, Keith Shankar-Hari, Manu Norrie, John Parker, Richard A. Akram, Ahsan R. Anthony, Daniel C. Dear, James W. Hirani, Nik Dhaliwal, Kevin